Journal of Inflammation-London

Journal of Inflammation welcomes research submissions on all aspects of inflammation. The five classical symptoms of inflammation, namely redness (rubor), swelling (tumour), heat (calor), pain (dolor) and loss of function (functio laesa), are only part of the story. The term inflammation is taken to include the full range of underlying cellular and molecular mechanisms involved, not only in the production of the inflammatory responses but, more importantly in clinical terms, in the healing process as well. Thus the journal covers molecular, cellular, animal and clinical studies, and related aspects of pharmacology, such as anti-inflammatory drug development, trials and therapeutic developments. It also considers publication of negative findings. Journal of Inflammation aims to become the leading online journal on inflammation and, as online journals replace printed ones over the next decade, the main open access inflammation journal. Open access guarantees a larger audience, and thus impact, than any restricted access equivalent, and increasingly so, as the escalating costs of printed journals puts them outside University budgets. The unrestricted access to research findings in inflammation aids in promoting dynamic and productive dialogue between industrial and academic members of the inflammation research community, which plays such an important part in the development of future generations of anti-inflammatory therapies.

Journal of Inflammation-London 欢迎提交关于炎症各个方面的研究论文。炎症不仅仅是指其五种典型症状——发红、肿胀、发热、疼痛和功能丧失，它还涵盖了所有潜在的细胞和分子机制，包括炎症的引发、传播、消退以及相关的修复过程。该杂志广泛覆盖了分子、细胞、动物和临床研究，以及药理学领域，特别是抗炎药物的开发、试验和治疗策略的发展，并考虑发表那些得出负面结果的研究。 Journal of Inflammation-London 的目标是成为领先的在线炎症学术期刊，并预计在未来十年内，随着在线出版逐渐取代传统印刷出版，成为主要的开放获取平台。开放获取模式确保了研究成果能够被更广泛的读者群体获取，从而产生更深远的影响。无限制地获取炎症研究成果有助于促进产业界和学术界成员之间就炎症研究进行活跃且富有成效的交流，这对于未来抗炎治疗策略的发展具有重要意义。